公司控股子公司安徽爱视睿本次增资扩股引入投资者为其注入运营资金，有利于其持续稳定的发展，将有助于加速推动公司打造以骨科手术机器人平台为核心的生态体系，完善公司产业布局，打造骨科手术全流程产品的服务能力，进一步提高公司核心竞争力。公司放弃安徽爱视睿本次增资优先认购权是综合考虑了公司自身的情况而作出的审慎决策，符合公司整体发展战略。Tianzhihang (688277.SH) announced that to promote the rapid development of its holding subsidiary Anhui Aishirui, An...
Zhito Finance APP news, Tianzhihang (688277.SH) announced that to promote the rapid development of its holding subsidiary Anhui Aishirui, Anhui Aishirui plans to introduce two investors through capital increase and share expansion: Tongling Gaotou Yida Specialized, Special and New Venture Capital Fund Partnership (Limited Partnership) (hereinafter referred to as 'Yida Tongling Fund') and Wuhu Jinghu Gaotou Yida Small and Medium Enterprises Venture Capital Fund (Limited Partnership) (hereinafter referred to as 'Yida Wuhu Fund').
Based on the recognition of Anhui Aishirui's future prospects, through friendly consultations among all parties, Anhui Aishirui is valued at 0.12 billion yuan. The above investors plan to subscribe for 2.483334 million yuan of registered capital of Anhui Aishirui for a total of 29.8 million yuan, corresponding to a 19.89% equity stake in Anhui Aishirui after the capital increase.
The introduction of investors in this capital increase and share expansion of the company's holding subsidiary Anhui Aishirui injects operating funds, which is conducive to its continuous and stable development and will help accelerate the company's creation of an ecosystem centered around the orthopedic surgical robot platform, improve the company's industrial layout, build service capabilities for the full-process products of orthopedic surgery, and further enhance the company's core competitiveness. The company's decision to waive its priority subscription rights for this capital increase in Anhui Aishirui is a prudent decision made considering the company's own circumstances, which aligns with the company's overall Global Strategy.